Literature DB >> 8246987

Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.

K V Prasad1, R Kapeller, O Janssen, H Repke, J S Duke-Cohan, L C Cantley, C E Rudd.   

Abstract

CD4 serves as a receptor for major histocompatibility complex class II antigens and as a receptor for the human immunodeficiency virus type 1 (HIV-1) viral coat protein gp120. It is coupled to the protein-tyrosine kinase p56lck, an interaction necessary for an optimal response of certain T cells to antigen. In addition to the protein-tyrosine kinase domain, p56lck possesses Src homology 2 and 3 (SH2 and SH3) domains as well as a unique N-terminal region. The mechanism by which p56lck generates intracellular signals is unclear, although it has the potential to interact with various downstream molecules. One such downstream target is the lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase), which has been found to bind to activated pp60src and receptor-tyrosine kinases. In this study, we verified that PI 3-kinase associates with the CD4:p56lck complex as judged by the presence of PI 3-phosphate generated from anti-CD4 immunoprecipitates and detected by high-pressure liquid chromatographic analysis. However, surprisingly, CD4-p56lck was also found to associate with another lipid kinase, phosphatidylinositol 4-kinase (PI 4-kinase). The level of associated PI 4-kinase was generally higher than PI 3-kinase activity. HIV-1 gp120 and antibody-mediated cross-linking induced a 5- to 10-fold increase in the level of CD4-associated PI 4- and PI 3-kinases. The use of glutathione S-transferase fusion proteins carrying Lck-SH2, Lck-SH3, and Lck-SH2/SH3 domains showed PI 3-kinase binding to the SH3 domain of p56lck, an interaction facilitated by the presence of an adjacent SH2 domain. PI 4-kinase bound to neither the SH2 nor the SH3 domain of p56lck. CD4-p56lck contributes PI 3- and PI 4-kinase to the activation process of T cells and may play a role in HIV-1-induced immune defects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246987      PMCID: PMC364842          DOI: 10.1128/mcb.13.12.7708-7717.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes.

Authors:  R J Juszczak; H Turchin; A Truneh; J Culp; S Kassis
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Profound block in thymocyte development in mice lacking p56lck.

Authors:  T J Molina; K Kishihara; D P Siderovski; W van Ewijk; A Narendran; E Timms; A Wakeham; C J Paige; K U Hartmann; A Veillette
Journal:  Nature       Date:  1992-05-14       Impact factor: 49.962

4.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Authors:  M Otsu; I Hiles; I Gout; M J Fry; F Ruiz-Larrea; G Panayotou; A Thompson; R Dhand; J Hsuan; N Totty
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

5.  Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes.

Authors:  J A Augustine; S L Sutor; R T Abraham
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

6.  Identification of distinct populations of PI-3 kinase activity following T-cell activation.

Authors:  P A Thompson; J S Gutkind; K C Robbins; J A Ledbetter; J B Bolen
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

7.  GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor beta subunit.

Authors:  A Kazlauskas; A Kashishian; J A Cooper; M Valius
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

8.  Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways.

Authors:  W J Fantl; J A Escobedo; G A Martin; C W Turck; M del Rosario; F McCormick; L T Williams
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

9.  Biochemical identification of a direct physical interaction between the CD4:p56lck and Ti(TcR)/CD3 complexes.

Authors:  K E Burgess; A D Odysseos; C Zalvan; B J Druker; P Anderson; S F Schlossman; C E Rudd
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

10.  Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C.

Authors:  N Mohagheghpour; R Chakrabarti; B S Stein; S D Gowda; E G Engleman
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

View more
  36 in total

1.  Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase.

Authors:  R L Yauch; M E Hemler
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

2.  Fyn kinase regulates type II PtdIns 4-kinases in RBL 2H3 cells.

Authors:  Naveen Bojjireddy; Ranjeet Kumar Sinha; Gosukonda Subrahmanyam
Journal:  Mol Cell Biochem       Date:  2013-10-31       Impact factor: 3.396

3.  Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.

Authors:  Z Weng; S M Thomas; R J Rickles; J A Taylor; A W Brauer; C Seidel-Dugan; W M Michael; G Dreyfuss; J S Brugge
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

4.  A Ras-GTPase-activating protein SH3-domain-binding protein.

Authors:  F Parker; F Maurier; I Delumeau; M Duchesne; D Faucher; L Debussche; A Dugue; F Schweighoffer; B Tocque
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

Review 5.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

6.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

7.  The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphorylation by, and stable complex formation with, Src.

Authors:  A C Guappone; D C Flynn
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

8.  Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases.

Authors:  J Wong; D Straus; A C Chan
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

9.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.

Authors:  L Briant; V Robert-Hebmann; C Acquaviva; A Pelchen-Matthews; M Marsh; C Devaux
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.